A systematic study on dysregulated microRNAs in cervical cancer development

International Journal of Cancer

Volumn 138, Issue 6, 2016, Pages 1312-1327

  He, Yuqing ^a   Lin, Juanjuan ^a   Ding, Yuanlin ^a   Liu, Guodong ^b   Luo, Yanhong ^a   Huang, Mingyuan ^a   Xu, Chengkai ^a   Kim, Taek Kyun ^c   Etheridge, Alton ^d   Lin, Mi ^a   Kong, Danli ^a   Wang, Kai ^c  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b NORTH DAKOTA STATE UNIVERSITY   (United States)

^c INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^d PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

Author keywords

cervical cancer; cervical intraepithelial neoplasia; gene set enrichment analysis; meta analysis; microRNA

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 100; MICRORNA 101; MICRORNA 126; MICRORNA 143; MICRORNA 145; MICRORNA 146A; MICRORNA 16; MICRORNA 169A; MICRORNA 181B; MICRORNA 192; MICRORNA 195; MICRORNA 196A; MICRORNA 199B; MICRORNA 21; MICRORNA 218; MICRORNA 25; MICRORNA 26A; MICRORNA 27A; MICRORNA 29A; MICRORNA 29C; MICRORNA 31; MICRORNA 376A; MICRORNA 424; MICRORNA 92A; MICRORNA 944; MICRORNA 96; PROTEIN P53; UNCLASSIFIED DRUG; UNINDEXED DRUG; MESSENGER RNA;

CANCER CLASSIFICATION; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CELL CYCLE; ENERGY METABOLISM; ETHNICITY; HUMAN; MICROARRAY ANALYSIS; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER; WNT SIGNALING PATHWAY; ANIMAL; CELL TRANSFORMATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; META ANALYSIS; METABOLISM; PATHOLOGY; RNA INTERFERENCE; UTERINE CERVIX TUMOR;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM STAGING; RNA INTERFERENCE; RNA, MESSENGER; SIGNAL TRANSDUCTION; UTERINE CERVICAL NEOPLASMS;

EID: 84954119936     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29618     Document Type: Review

References (91)

1. I.A.f.R.o. Cancer, GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012, World Health Organization. Available at: http://globocan.iarc.fr/Pages/fact-sheets-cancer.aspx. Accessed on, 9 (2014).
2. Ferlay J, Shin HR, Bray F, et al., Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
3. Shai A, Brake T, Somoza C, et al., The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities. Cancer Res 2007; 67: 1626-35.
4. Gõmez-Gõmez Y, Organista-Nava J, Gariglio P., Deregulation of the miRNAs expression in cervical cancer: human papillomavirus implications. BioMed Res Int 2013: 407052.
5. Wang X, Tang S, Le SY, et al., Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PloS One 2008; 3: e2557.
6. Wang X, Wang HK, Li Y, et al., microRNAs are biomarkers of oncogenic human papillomavirus infections. Proc Natl Acad Sci USA 2014; 111: 4262-7.
7. Esteller M., Non-coding RNAs in human disease. Nat Rev Genet 2011; 12: 861-74.
8. Griffiths-Jones S, Saini HK, van Dongen S, et al., miRBase: tools for microRNA genomics. Nucleic Acids Res 2008; 36: D154-8.
9. Kellis M, Wold B, Snyder MP, et al., Defining functional DNA elements in the human genome. Proc Natl Acad Sci USA 2014; 111: 6131-8.
10. Lui WO, Pourmand N, Patterson BK, et al., Patterns of known and novel small RNAs in human cervical cancer. Cancer Res 2007; 67: 6031-43.
11. Hou T, Ou J, Zhao X, et al., MicroRNA-196a promotes cervical cancer proliferation through the regulation of FOXO1 and p27Kip1. Br J Cancer 2014; 110: 1260-8.
12. Shi J, Zhang L., Clinical significance of miR-27a expression in the serum and tissue of patients with cervical squamous cell carcinomas. Chin J Clin Obstet Gynecol 2014; 49: 172-174.
13. Zeng K, Mo X, Liu F, Hu X,. Differential expression of microRNAs in cervical cancer and cervical precancerous lesions. Cancer Res Prev Treat 2014; 7: 024.
14. Chen L, Fei H, Zhang YJ, et al., Roles of MiR-101 and its target gene Cox-2 in early diagnosis of cervical cancer in Uygur women. Asian Pac J Cancer Prevent 2014; 15: 45-8.
15. Huang T, Chu T., Repression of miR-126 and upregulation of adrenomedullin in the stromal endothelium by cancer-stromal cross talks confers angiogenesis of cervical cancer. Oncogene 2014; 33: 3636-3647.
16. Xie H, Lee L, Scicluna P, et al., Novel functions and targets of miR-944 in human cervical cancer cells. Int J Cancer 2015; 136: E230-241.
17. Lao G, Liu P, Wu Q, et al., Mir-155 promotes cervical cancer cell proliferation through suppression of its target gene LKB1. Tumor Biol 2014; 35: 11933-11938.
18. Wang L, Chang L, Li Z, et al., miR-99a and -99b inhibit cervical cancer cell proliferation and invasion by targeting mTOR signaling pathway. Med Oncol 2014; 31: 934.
19. Yuan W, Xiaoyun H, Haifeng Q, et al., MicroRNA-218 enhances the radiosensitivity of human cervical cancer via promoting radiation induced apoptosis. Int J Med Sci 2014; 11: 691.
20. Che Y, Lu A, Liao Y., Expression of miR-143 in cervical tissue and its significance. J Med Postgra 2014; 27: 510-2.
21. Dong J, Sui L, Wang Q, et al., MicroRNA-26a inhibits cell proliferation and invasion of cervical cancer cells by targeting protein tyrosine phosphatase type IVA 1. Mol Med Rep 2014; 10: 1426-32.
22. Li H, Sun J,. Value of MicroRNA-21 in early diagnosis of cervical cancer. J Qiqihar Univ Med 2014; 481-482.
23. Liu J, Sun H, Wang X, et al., Increased exosomal MicroRNA-21 and MicroRNA-146a levels in the cervicovaginal lavage specimens of patients with cervical cancer. Int J Mol Sci 2014; 15: 758-73.
24. Villegas-Ruiz V, Juárez-Méndez S, Pérez-González OA, et al., Heterogeneity of microRNAs expression in cervical cancer cells: over-expression of miR-196a. Int J Clin Exp Pathol 2014; 7: 1389.
25. Zhou W, Hao C, Guan T., Expression and clinical significances of Has-miRNA-96 in tissues of cervical cancer. J Chongqing Med Univ 2014; 39: 405-8.
26. Park H, Lee MJ, Jeong JY, et al., Dysregulated microRNA expression in adenocarcinoma of the uterine cervix: clinical impact of miR-363-3p. Gynecol Oncol 2014; 135: 565-572.
27. Chen Y, Ma C, Zhang W, et al., Down regulation of miR-143 is related with tumor size, lymph node metastasis and HPV16 infection in cervical squamous cancer. Diagn Pathol 2014; 9: 88.
28. Bierkens M, Krijgsman O, Wilting SM, et al., Focal aberrations indicate EYA2 and hsa-miR-375 as oncogene and tumor suppressor in cervical carcinogenesis. Genes Chromosomes Cancer 2013; 52: 56-68.
29. Yamamoto N, Kinoshita T, Nohata N, et al., Tumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma. Int J Oncol 2013; 43: 1855-1863.
30. Wu M, Hu Z, Zhang J., Expression of miR143 and its primary transcript in squamous cell carcinoma of cervix. J Chin Oncol 2013; 373-7.
31. Yu Q, Liu SL, Wang H, et al., miR-126 suppresses the proliferation of cervical cancer cells and alters cell sensitivity to the chemotherapeutic drug bleomycin. Asian Pac J Cancer Prevent 2013; 14: 6569-72.
32. Wu Y., Expression and significance of MiR-29a in cervical cancer tissues. Chin J Gen Practice 2013; 11: 1401-2.
33. Luo M, Shen D, Zhou X, et al., MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor. Surgery 2013; 153: 836-847.
34. Chen Y, Ma C, Chen Z, Zhang W,. Clinical significance of miR-143expressionin women with cervical cancer of Uyghurand Hanethnicities, in Xinjiang. Zhonghua Liu Xing Bing Xue Za Zhi 2013; 34: 1120-4.
35. Liu S, Zhang P, Chen Z, et al., MicroRNA-7 downregulates XIAP expression to suppress cell growth and promote apoptosis in cervical cancer cells. FEBS Lett 2013; 587: 2247-53.
36. Wilting S, Snijders P, Verlaat W, et al., Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis. Oncogene 2012; 32: 106-116.
37. Chen J, Yao D, Li Y, et al., Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma. Int J Mol Med 2013; 32: 557-67.
38. Zhao S, Yao DS, Chen JY, et al., Aberrant expression of miR-20a and miR-203 in cervical cancer. Asian Pac J Cancer Prev 2013; 14: 2289-93.
39. Wang F, Liu M, Li X, et al., MiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells. FEBS Lett 2013; 587: 488-95.
40. Xing AY, Wang B, Shi DB, et al., Deregulated expression of miR-145 in manifold human cancer cells. Exp Mol Pathol 2013; 95: 91-7.
41. How C, Hui AB, Alajez NM, et al., MicroRNA-196b regulates the homeobox B7-vascular endothelial growth factor axis in cervical cancer. PloS One 2013; 8: e67846.
42. Zhu X, Er K, Mao C, et al., miR-203 suppresses tumor growth and angiogenesis by targeting VEGFA in cervical cancer. Cell Physiol Biochem 2013; 32: 64-73.
43. Xu J, Li Y, Wang F, et al., Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer. Oncogene 2013; 32: 976-87.
44. Yamamoto N, Kinoshita T, Nohata N, et al., Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma. Int J Oncol 2013; 42: 1523-32.
45. Shen S, Wang L, Jia Y, et al., Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer. Diagn Pathol 2013; 8: 69.
46. Rao Q, Zhou H, Peng Y, et al., Aberrant microRNA expression in human cervical carcinomas. Med Oncol 2012; 29: 1242-8.
47. Cheung T, Man K, Yu M, et al., Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm. Cell Cycle 2012; 11: 2876-84.
48. Long MJ, Wu FX, Li P, et al., MicroRNA-10a targets CHL1 and promotes cell growth, migration and invasion in human cervical cancer cells. Cancer Lett 2012; 324: 186-96.
49. Ma D, Zhang Y, Guo Y, et al., Profiling of microRNA-mRNA reveals roles of microRNAs in cervical cancer. Chin Med J (Engl) 2012; 125: 4270-6.
50. Wei Q, Li YX, Liu M, et al., MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells. IUBMB Life 2012; 64: 697-704.
51. Lajer C, Garnæs E, Friis-Hansen L, et al., The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer. Br J Cancer 2012; 106: 1526-1534.
52. Xu XM, Wang XB, Chen MM, et al., MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5. Cancer Lett 2012; 322: 148-58.
53. Kang HW, Wang F, Wei Q, et al., miR-20a promotes migration and invasion by regulating TNKS2 in human cervical cancer cells. FEBS Lett 2012; 586: 897-904.
54. Qin W, Dong P, Ma C, et al., MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways. Oncogene 2011; 31: 4067-75.
55. Liu L, Yu X, Guo X, et al., miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2. Mol Med Rep 2012; 5: 753-60.
56. Xie H, Zhao Y, Caramuta S, et al., miR-205 expression promotes cell proliferation and migration of human cervical cancer cells. PloS One 2012; 7: e46990.
57. Ye J, Lin C, Yun J, Gulinar K,. Expression of miRNA-101 and its relationship with HPV in cervical carcinoma tissue and CIN of Uyghur women. Chongqing Med J 2012; 41: 2810-1.
58. Zhang Y, Ding X., Hsa-miRNA-199a-5p expression changes in cervical cancer tissues. Shandong Med 2012; 52: 40-2.
59. Li S, Wang X, Song B, Zhou Y., Expression of miR-199b in cervical cancer tissues and its clinical significance. Chin J Cancer Prev Treat 2012; 1335-1338.
60. Yao T, Lin Z., MiR-21 is involved in cervical squamous cell tumorigenesis and regulates CCL20. Biochim Biophys Acta Mol Basis Dis 2012; 1822: 248-60.
61. Gai H., Preliminary research on the correlation between miR-218 down-regulation and cervical cancer. Clin Res 2012; 50: 28-9.
62. Li-fen G., Clinical significance of miR-145 expression in cervical cancer and cervical intraepithelial neoplasia. China J Mod Med 2012; 31: 015.
63. Cheng J, Zhao H, Yin YX., Expression of miR-101 in cervical cancer tissue and its clinical significance. Maternal Child Health Care China 2012; 7: 053.
64. Liu L, Wang Y, Wang J., Differential expression of miR-21, miR-126, miR-143, miR-373 in normal cervical tissue, cervical cancer tissue and Hela cell. Sichuan da xue xue bao Yi xue ban J Sichuan Univ Med Sci Ed 2012; 43: 536-539.
65. Peng RQ, Wan HY, Li HF, et al., MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-α-d-galactosamine: polypeptide N-acetylgalactosaminyltransferase 7. J Biol Chem 2012; 287: 14301-14309.
66. Shi M, Du L, Liu D, et al., Glucocorticoid regulation of a novel HPV-E6-p53-miR-145 pathway modulates invasion and therapy resistance of cervical cancer cells. J Pathol 2012; 228: 148-57.
67. Li Y, Wang F, Xu J, et al., Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29. J Pathol 2011; 224: 484-95.
68. Li BH, Zhou JS, Ye F, et al., Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein. Eur J Cancer 2011; 47: 2166-74.
69. Shen Y, Li Y, Ye F, et al., Identification of miR-23a as a novel microRNA normalizer for relative quantification in human uterine cervical tissues. Exp Mol Med 2011; 43: 358-66.
70. Zou HZ, Chen RM, Zhang H, et al., Clinical significance of miR-199a expression in cervical cancer and cervical intraepithelial neoplasia. J Med Res 2011; 40: 55-59.
71. Qiang R, Wang F, Shi LY, et al., Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of HeLa cells. Int J Biochem Cell Biol 2011; 43: 632-41.
72. Wang F, Li Y, Zhou J, et al., miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1. Am J Pathol 2011; 179: 2580-8.
73. Deftereos G, Corrie SR, Feng Q, et al., Expression of mir-21 and mir-143 in cervical specimens ranging from histologically normal through to invasive cervical cancer. PloS One 2011; 6: e28423.
74. Witten D, Tibshirani R, Gu SG, et al., Ultra-high throughput sequencing-based small RNA discovery and discrete statistical biomarker analysis in a collection of cervical tumours and matched controls. BMC Biol 2010; 8: 58.
75. Pereira PM, Marques JP, Soares AR, et al., MicroRNA expression variability in human cervical tissues. PloS One 2010; 5: e11780.
76. Li B, Hu Y, Ye F, et al., Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection. Int J Gynecol Cancer 2010; 20: 597-604.
77. Li L, Lin X, Wen W., Development and clinical primary application of SYBR Green I FQ-PCR with stem-loop RT primer to detect miR-155 [J]. Lab Med 2010; 4: 011.
78. Zhang Z, Luo D, Cui J,. Study of over-expression of miRNA-200b in cervical cancer. Chin J Practical Gynecol Obstet 2010; 386-387.
79. Zhang Y, Dai Y, Huang Y, et al., Microarray profile of micro-ribonucleic acid in tumor tissue from cervical squamous cell carcinoma without human papillomavirus. J Obstet Gynaecol Res 2009; 35: 842-9.
80. Wang X, Wang HK, McCoy JP, et al., Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA 2009; 15: 637-47.
81. Yang Z, Chen S, Luan X, et al., MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells. IUBMB Life 2009; 61: 1075-82.
82. Lee JW, Choi CH, Choi JJ, et al., Altered MicroRNA expression in cervical carcinomas. Clin Cancer Res 2008; 14: 2535-42.
83. Martinez I, Gardiner A, Board K, et al., Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 2007; 27: 2575-82.
84. Muralidhar B, Goldstein L, Ng G, et al., Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels. J Pathol 2007; 212: 368-377.
85. Ribeiro J, Sousa H., MicroRNAs as biomarkers of cervical cancer development: a literature review on miR-125b and miR-34a. Mol Biol Rep 2014; 41: 1525-31.
86. Hongxia, G., Preliminary research on the correlation between miR-218 down-regulation and cervical cancer. China Mod Doctor 2012; 50: 28-9, 32.
87. Huang L, Lin JX, Yu YH, et al., Downregulation of six microRNAs is associated with advanced stage, lymph node metastasis and poor prognosis in small cell carcinoma of the cervix. PloS One 2012; 7: e33762.
88. Dai Y, Xia W, Song T, et al., MicroRNA-200b is overexpressed in endometrial adenocarcinomas and enhances MMP2 activity by downregulating TIMP2 in human endometrial cancer cell line HEC-1A cells. Nucleic Acid Ther 2013; 23: 29-34.
89. Kim MK, Jung SB, Kim JS, et al., Expression of microRNA miR-126 and miR-200c is associated with prognosis in patients with non-small cell lung cancer. Virchows Arch 2014; 465: 463-71.
90. Wang M, Zhang P, Li Y, et al., The quantitative analysis by stem-loop real-time PCR revealed the microRNA-34a, microRNA-155 and microRNA-200c overexpression in human colorectal cancer. Med Oncol 2012; 29: 3113-8.
91. Chen Z, Saad R, Jia P, et al., Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma. Cancer 2013; 119: 1985-93.